FEATURED ISHARES ETFS
Models & SMAs
To reach a different BlackRock site directly, please update your user type.
$1 Trillion on U.S infrastructure
U.S. infrastructure spending is set to accelerate over the next decade from $400B (2010-2020) to about $1Trillion (2020-2029).1
Outperformance in inflationary environments
Global infrastructure has historically outperformed in inflationary environments, with positive average annualized return.2
Lowest cost access to U.S. infrastructure
At 0.30% expense ratio, IFRA is ranked the lowest cost U.S. infrastructure ETF.3
Genome sequencing becomes commercially viable
Sequencing a human genome is cheaper today than it has ever been (~170,000x cheaper today than two decades ago).5 More affordable genetic insights will increase drug development efforts.
Gain exposure to innovation in healthcare
IDNA provides access to companies leading the way in genomics, immunology, and bioengineering.
Genome sequencing becomes commercially viable
At 0.47% expense ratio, IDNA is ranked less expensive than 85% of the funds in its category.6
Better, stronger, faster
The number of industrial robots is expected to double between 2019 and 2025.8
Access opportunities in robotics and AI
IRBO provides access to companies that may benefit from innovation in robotics and AI - from delivery and warehouse robots to the companies providing analytics enabling transformations across sectors.
Lowest cost
At 0.47% expense ratio, IRBO is ranked less expensive than 85% of the funds in its category.9